-
Product Insights
NewLikelihood of Approval Analysis for Myocardial Infarction
Overview How likely is it that the drugs in Myocardial Infarction will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myocardial Infarction Overview Myocardial infarction is the irreversible necrosis of heart muscle...
-
Thematic Analysis
Scaling Rearmament – Thematic Intelligence
Reasons to buy the ‘Scaling Rearmament’ thematic intelligence report: Obtain in-depth insights into different rearmament efforts being undertaken by various military organizations and defense companies to understand the market better. Study the emerging trends and how they will influence the scaling rearmament theme and their broader impact on the defense market. Get an overview of the specific drivers of large-scale rearmament today, as well as the challenges that forces and defense sector suppliers face. Explore thematic investment opportunities for armed...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Peripheral Neuropathy
Overview How likely is it that the drugs in Diabetic Peripheral Neuropathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Peripheral Neuropathy Overview Diabetic neuropathy is nerve damage caused by...
-
Product Insights
NewLikelihood of Approval Analysis for Upper Limb Muscle Spasticity
Overview How likely is it that the drugs in Upper Limb Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upper Limb Muscle Spasticity Overview Spasms or spasticity is a...
-
Product Insights
NewLikelihood of Approval Analysis for Cerebrovascular Disease
Overview How likely is it that the drugs in Cerebrovascular Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cerebrovascular Disease Overview Cerebrovascular disease refers to a group of conditions that...
-
Product Insights
NewLikelihood of Approval Analysis for Venous Thromboembolism
Overview How likely is it that the drugs in Venous Thromboembolism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venous Thromboembolism Overview Venous thromboembolism (VTE) is a condition that occurs when...
-
Product Insights
NewLikelihood of Approval Analysis for Venous (Vein) Thrombosis
Overview How likely is it that the drugs in Venous (Vein) Thrombosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venous (Vein) Thrombosis Overview Venous thromboembolism (VTE) is a condition characterized...
-
Product Insights
NewLikelihood of Approval Analysis for Amyotrophic Lateral Sclerosis
Overview How likely is it that the drugs in Amyotrophic Lateral Sclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyotrophic Lateral Sclerosis Overview Amyotrophic lateral sclerosis (ALS), also known as...
-
Thematic Analysis
NewSemiconductors Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Companies scoring strongly in artificial intelligence (AI) and geopolitics-related themes lead the thematic screen of GlobalData’s semiconductors sector scorecard. Indeed, the AI, AI chips, geopolitics, and China impact themes jointly account for 50% of the weighting of the thematic screen, reflecting both the growing importance of AI, particularly generative AI, in the industry and the impact of the ongoing US-China trade dispute. Among the thematic leaders are companies with either advanced AI products, such as Nvidia, Amazon, Tesla, and Alibaba,...
-
Sector Analysis
NewUnited Arab Emirates (UAE) Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
United Arab Emirates (UAE) Defense Market Report Overview The United Arab Emirates (UAE) defense budget is estimated to be valued at $25 billion in 2024, due to the need to finance procurements. The country’s defense budget will grow at a CAGR of more than 4% during 2025-2029, owing to the need to modernize the UAE Defense and Security Forces, with specific emphasis on counter-insurgency measures. United Arab Emirates (UAE) Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for...